We have evaluated the cellular and humoral immune response to primary respiratory syncytial virus (RSV) infection in young infants. Serum specimens from 65 patients <=12 months of age (39 males and 26 females, 28 cases <3 months and 37 cases > or = 3 months; median 3 ± 3.9 months) were tested for anti-RSV IgG and IgG subclass antibodies by EIA. Flow cytometry was used to characterize cell surface markers expressed on peripheral blood mononuclear cells (PBMC) from 29 RSV-infected children. There was a low rate of seroconversion in children <3 months of age, whose acute-phase PBMC were mostly T lymphocytes (63.0 ± 9.0%). In contrast, a higher rate of seroconversion was observed in children >3 months of age, with predominance of B lymphocytes...
Respiratory syncytial virus (RSV) infections are a major cause of severe respiratory disease in infa...
Employing in vitro cultured and virus-infected autologous monocytes as target cells, responses of cy...
Employing in vitro cultured and virus-infected autologous monocytes as target cells, responses of cy...
Groups of infants and children with infections due to respiratory syncytial virus (RSV) were tested ...
Respiratory syncytial virus (RSV) is one of the most prevalent causative agents of lower respiratory...
The development of a safe and effective respiratory syncytial virus (RSV) vaccine might be facilitat...
The development of a safe and effective respiratory syncytial virus (RSV) vaccine might be facilitat...
The development of a safe and effective respiratory syncytial virus (RSV) vaccine might be facilitat...
Background Respiratory syncytial virus (RSV) causes respiratory disease throughout life. Here we re...
The development of a safe and effective respiratory syncytial virus (RSV) vaccine might be facilitat...
textabstractThe decline of maternal respiratory syncytial virus (RSV) specific serum antibodies was ...
Humoral immunityprotects against severe respiratory syncytial virus (RSV)disease, but the range andm...
ABSTRACT: The development of a safe and effective respiratory syncytial virus (RSV) vaccine might be...
ABSTRACT: The development of a safe and effective respiratory syncytial virus (RSV) vaccine might be...
ABSTRACT: The development of a safe and effective respiratory syncytial virus (RSV) vaccine might be...
Respiratory syncytial virus (RSV) infections are a major cause of severe respiratory disease in infa...
Employing in vitro cultured and virus-infected autologous monocytes as target cells, responses of cy...
Employing in vitro cultured and virus-infected autologous monocytes as target cells, responses of cy...
Groups of infants and children with infections due to respiratory syncytial virus (RSV) were tested ...
Respiratory syncytial virus (RSV) is one of the most prevalent causative agents of lower respiratory...
The development of a safe and effective respiratory syncytial virus (RSV) vaccine might be facilitat...
The development of a safe and effective respiratory syncytial virus (RSV) vaccine might be facilitat...
The development of a safe and effective respiratory syncytial virus (RSV) vaccine might be facilitat...
Background Respiratory syncytial virus (RSV) causes respiratory disease throughout life. Here we re...
The development of a safe and effective respiratory syncytial virus (RSV) vaccine might be facilitat...
textabstractThe decline of maternal respiratory syncytial virus (RSV) specific serum antibodies was ...
Humoral immunityprotects against severe respiratory syncytial virus (RSV)disease, but the range andm...
ABSTRACT: The development of a safe and effective respiratory syncytial virus (RSV) vaccine might be...
ABSTRACT: The development of a safe and effective respiratory syncytial virus (RSV) vaccine might be...
ABSTRACT: The development of a safe and effective respiratory syncytial virus (RSV) vaccine might be...
Respiratory syncytial virus (RSV) infections are a major cause of severe respiratory disease in infa...
Employing in vitro cultured and virus-infected autologous monocytes as target cells, responses of cy...
Employing in vitro cultured and virus-infected autologous monocytes as target cells, responses of cy...